亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

How Do We Bridge the Gap Between Animal Models of Sepsis and Patients?

败血症 医学 重症监护医学 重症监护室 人口 感染性休克 糖尿病 流行病学 病因学 内科学 内分泌学 环境卫生
作者
Naoki Hayase,Kent Doi
出处
期刊:Kidney360 [American Society of Nephrology (ASN)]
卷期号:5 (5): 637-638 被引量:1
标识
DOI:10.34067/kid.0000000000000458
摘要

Sepsis accounts for more than 50% of hospital deaths in the United States, and the cost of sepsis treatment ranks at the top of the list.1 Unfortunately, we do not have definitive therapeutic strategies for sepsis beyond supportive care. Although there are numbers of preclinical studies that report positive results of promising drugs, most of the results obtained by animal sepsis models have failed to be translated to the clinical. For example, the effectiveness of anti–tumor necrosis factor-α therapy was proven in lipopolysaccharide-induced septic animals, whereas the drug against tumor necrosis factor-α failed to improve the survival of septic patients in the clinical trial.2 Why did that happen? Such translation failure could be mainly attributed to the disparity between animal sepsis models and patients.3,4 There are multiple possible reasons for this gap. The etiologies of human sepsis are more complex and multifactorial. In most septic animals, drug administration is often initiated before or a few hours after septic insults while septic patients are seldom treated in such early window.3 Among the reasons, it is notable that animal sepsis studies using healthy individuals cannot recapitulate human septic population. Reflecting the aging society, a growing number of patients in intensive care unit (ICU) present with one or more comorbidities. In addition, a recent epidemiological study showed that sepsis most frequently occurred among the patients with preexisting comorbid conditions such as CKD, liver disease, and diabetes mellitus with very high mortality in these patient population.5 It might be important to study sepsis in animal models complicated with preexisting chronic diseases. However, there have been few studies to address this reverse-modeling from bedside to bench because of its technical difficulty and labor-intensive process. Two-stage mouse models of preexisting renal disease with subsequent cecum ligation and puncture (CLP)–induced sepsis have been developed.6,7 These CKD–sepsis models increased vascular permeability in the lung and blood proinflammatory cytokines and decreased bacterial clearance compared with the septic mice without CKD. Interestingly, soluble fms-like tyrosine kinase 1 (a soluble vascular endothelial growth factor receptor), which improved the survival of the CKD–sepsis mice, were ineffective in the septic mice without CKD. These findings suggested the septic animals with comorbidities have some distinct difference in underlying pathophysiological mechanisms of sepsis development from sepsis models in healthy animals. In this issue of Kidney360, Floyd and colleagues reported a novel two-stage mouse model of sepsis complicated with preexisting acute kidney disease (AKD) or CKD to replicate the complexity and common clinical profile of septic patients.8 They induced experimental AKD and CKD using aristolochic acid (AA) and superimposed cecal slurry (CS) injection-induced sepsis on them. This study exceled at the following points; first, they developed stable AA-induced AKD and CKD with the small variation of GFR. Second, sepsis severity was successfully adjusted by titrating the dose of the CS to enable them to assess the longitudinal change of organ injury markers and immune response during the development of sepsis. CLP has been well recognized as a gold standard of sepsis animal model. However, CLP tends to cause high disease severity because it involves major surgery, prolonged anesthesia, and ischemic insult by ligation of cecum. On the other hand, CS implantation is the emerging strategy to induce polymicrobial sepsis. As they mentioned, it can generate dose-dependent sepsis severity and avoid unnecessary surgical and anesthetic insults. It should be noted that AKD mice with subsequent sepsis had higher mortality and sepsis severity than CKD mice even though AKD mice received less cumulative amount of AA and higher GFR in this study. AKD–sepsis mice also showed distant organ injuries, decreased bacterial clearance, and acute elevation of proinflammatory and anti-inflammatory cytokines. The flow cytometry showed persistent significant neutropenia in those mice while less reduction of neutrophils was observed in CKD-sepsis mice. Currently, AKD and CKD are defined by different diagnosis criteria with different observation periods. AKD, including AKI, is defined by functional and/or structural abnormalities for ≤3 months. CKD is defined by markers of kidney damage or decreased GFR persisting for >3 months. Reportedly, the uremic state in advanced CKD and end-stage renal disease are also associated with impaired innate and adaptive immune system,9 which could contribute to the higher sepsis severity of septic mice with preexisting CKD than those without CKD. However, it is still obscure whether this immunological change caused poor prognosis of AKD-sepsis mice. It is also unclear why does the shorter period of renal dysfunction in AKD cause more severe organ dysfunctions and immunological disorders. In addition, the clinical relevance of AA could be limited because of the infrequency of AA nephropathy in human. Further research is warranted to elucidate underlying mechanism for higher mortality and severity of AKD–sepsis mice. To increase clinical relevance of sepsis animal models, the following points should be considered. First, the difference in sex and age might affect the sepsis severity. Elderly patients are predominant in ICU patient population. Most of the animal sepsis studies involve only male patients, whereas female patients account for just less than 50% of septic patients.10 Second, it might be better to incorporate the treatments used in clinical ICU settings (e.g., antibiotics, source control, and sedation/analgesia). Third, their study results should be confirmed in the mouse models with sepsis superimposed on other chronic diseases such as diabetes and heart failure to increase generalizability. Finally, future multicenter preclinical studies could be warranted for overcoming limitations of a single-laboratory study. In summary, previous failures of translation from the bench to the bedside in sepsis treatment underscores the unfilled gap between animal sepsis model and patients and the necessity to develop more clinically relevant sepsis models. Floyd and colleagues generated their novel mouse model of sepsis superimposed on preexisting kidney disease, suggesting that patients with AKD may be more vulnerable to subsequent sepsis than patients with CKD. This finding may indicate a novel mechanism of disease in sepsis, which can be a target for specific therapy against sepsis.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
SciGPT应助awa606采纳,获得10
4秒前
默天完成签到 ,获得积分10
23秒前
梦里花落知多少完成签到,获得积分10
26秒前
27秒前
完美世界应助你hao采纳,获得10
33秒前
年年有余完成签到,获得积分10
38秒前
39秒前
40秒前
你hao发布了新的文献求助10
44秒前
bc老师完成签到,获得积分10
52秒前
你hao完成签到,获得积分10
54秒前
顾矜应助awa606采纳,获得10
1分钟前
Nick_YFWS完成签到,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
bc老师发布了新的文献求助10
1分钟前
bc老师发布了新的文献求助10
1分钟前
bc老师发布了新的文献求助10
1分钟前
bc老师发布了新的文献求助10
1分钟前
awa606发布了新的文献求助10
1分钟前
1分钟前
荷西完成签到,获得积分10
1分钟前
1分钟前
stuhwt发布了新的文献求助10
1分钟前
1分钟前
Copyright应助科研通管家采纳,获得10
1分钟前
wanci应助科研通管家采纳,获得10
1分钟前
1分钟前
哲000发布了新的文献求助10
1分钟前
2分钟前
科研通AI6.3应助gurdeva采纳,获得10
2分钟前
隐形曼青应助awa606采纳,获得10
2分钟前
太阳当空照完成签到,获得积分10
2分钟前
汉堡包应助reborn采纳,获得10
2分钟前
2分钟前
空空完成签到,获得积分10
2分钟前
2分钟前
2分钟前
小二郎应助酰胺back采纳,获得10
2分钟前
高分求助中
Principles of Economics, 11th Edition 10000
University Physics with Modern Physics, 16th edition 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Arthritis and Related Conditions, An Issue of Orthopedic Clinics 1000
Development of a Bridge Weigh-In-Motion System: A technology to convert the bridge response to the passage of traffic into data on vehicle configurations, speeds, times of travel and weights 1000
ズームレンズの光学設計に関する研究 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7289688
求助须知:如何正确求助?哪些是违规求助? 8909091
关于积分的说明 18856400
捐赠科研通 6957764
什么是DOI,文献DOI怎么找? 3209064
关于科研通互助平台的介绍 2378801
邀请新用户注册赠送积分活动 2184817